10:00 to 11:00
Seminar

The finance function in the development of high-potential biotech companies

André Mueller
Biotechnology and society
10:00 to 11:00
    Marguerite-de-Navarre Amphitheater, Marcelin-Berthelot Site
    Open to all, subject to availability
    -

    Documents and media

    Speaker(s)

    André Mueller

    Member of the Board of Directors of Actelion Phamarceuticals Ltd

    Events

    Setting up a biotech company. From innovative concept to first steps
    Jean-Paul Clozel

    Lecture
    10:00 to 11:00

    Setting up a biotech company. From first steps to IPO
    Jean-Paul Clozel

    Lecture
    11:00 to 12:00

    Drug discovery in biotechnology. Research or innovation ?
    Jean-Paul Clozel

    Lecture
    10:00 to 11:00

    Biotechnology drug discovery. From product to drug
    Jean-Paul Clozel

    Lecture
    11:00 to 12:00

    Biotechnology drug discovery. Biotech drug development
    Jean-Paul Clozel

    Lecture
    10:00 to 11:00

    Drug discovery in biotechnology. Biotechnology : What's the right business model?
    Jean-Paul Clozel

    Lecture
    11:00 to 12:00

    Drug discovery in biotechnology.…
    Jean-Paul Clozel

    Lecture
    10:00 to 11:00

    Drug discovery in biotechnology. Biotechnology in society : tomorrow's major challenges
    Jean-Paul Clozel

    Lecture
    11:00 to 12:00

    Opening
    Jean-Paul Clozel

    Seminar
    09:00 to 10:00

    Founding a biotech company. The role of venture capital
    Denis Lucquin

    Seminar
    09:30 to 10:30

    The finance function in the development of high-potential biotech companies
    André Mueller

    Seminar
    10:00 to 11:00

    The importance of intellectual property in biotechnology
    Jean-Christophe Galloux

    Seminar
    11:00 to 12:00

    Biotechnology and University. Biotechnology drug discovery : from idea to product
    Martine Clozel

    Seminar
    11:30 to 12:30

    Academic medicine and therapeutic research
    Joël Ménard

    Seminar
    12:00 to 13:00

    Biotechnology in society. Biotechnology and drug costs
    Noel Renaudin

    Seminar
    12:30 to 13:30

    Biotechnology and Big Pharma
    Guy Eiferman

    Seminar
    12:30 to 13:30

    Emerging infectious diseases
    Antoine Flahaut

    Seminar
    13:00 to 14:00

    Biotechnology in the United States : reasons for success
    François Maisonrouge

    Seminar
    13:30 to 14:30

    Biotechnology in Spain : the example of the Botín Foundation
    Rafaël Benjumea

    Seminar
    14:00 to 15:00

    See also

    Lecture related to the seminar: Biotechnology : from science to medicine
    Jean-Paul Clozel, chair Technological innovation Liliane Bettencourt
    Biotechnology and society